# The Use of Early Pregnancy HbA1c in Predicting Excessive Fetal Growth in Women at Risk of Glucose Intolerance

> **NCT04858386** · — · TERMINATED · sponsor: **Belfast Health and Social Care Trust** · enrollment: 1314 (actual)

## Conditions studied

- Gestational Diabetes

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04858386
- **Lead sponsor:** Belfast Health and Social Care Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2017-11-01
- **Primary completion:** 2020-03-21
- **Final completion:** 2020-08-04
- **Target enrollment:** 1314 (ACTUAL)
- **Why stopped:** Covid-19
- **Last updated:** 2021-04-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04858386

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04858386, "The Use of Early Pregnancy HbA1c in Predicting Excessive Fetal Growth in Women at Risk of Glucose Intolerance". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04858386. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*